CXCR4 and non-small cell lung carcinoma: employed multiple markers to validate endothelial classification in non-small cell lung cancer, using CD31+/C-X-C Motif Chemokine Receptor 4 (CXCR4), vWF, and EFNB2 to differentiate high-tip cells, veins, and arteries in human TECs.